Avantor, Inc. (AVTR) |
| 14.81 -0.07 (-0.47%) 09-11 16:00 |
| Open: | 15.01 |
| High: | 15.05 |
| Low: | 14.7 |
| Volume: | 6,179,013 |
| Market Cap: | 10,017(M) |
| PE Ratio: | 17.42 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 18.06 |
| Resistance 1: | 15.46 |
| Pivot price: | 14.68 |
| Support 1: | 14.08 |
| Support 2: | 13.23 |
| 52w High: | 15.93 |
| 52w Low: | 7.265 |
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
| EPS | -0.850 |
| Book Value | 8.320 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.090 |
| Profit Margin (%) | -8.81 |
| Operating Margin (%) | 7.16 |
| Return on Assets (ttm) | 2.7 |
| Return on Equity (ttm) | -9.7 |
Thu, 10 Sep 2026
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Mon, 07 Sep 2026
Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Landscape with a Forward P/E of 16.98 - DirectorsTalk Interviews
Fri, 04 Sep 2026
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Mon, 31 Aug 2026
Avantor, Inc. (AVTR) Stock Analysis: Evaluating Its Modest Growth Potential Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Fri, 28 Aug 2026
Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report? - Yahoo Finance
Wed, 19 Aug 2026
Is Avantor (AVTR) Outperforming Other Medical Stocks This Year? - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |